These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 32236582

  • 1. Altered expression of 17‑β‑hydroxysteroid dehydrogenase type 2 and its prognostic significance in non‑small cell lung cancer.
    Drzewiecka H, Jarmołowska-Jurczyszyn D, Kluk A, Gałęcki B, Dyszkiewicz W, Jagodziński PP.
    Int J Oncol; 2020 Jun; 56(6):1352-1372. PubMed ID: 32236582
    [Abstract] [Full Text] [Related]

  • 2. Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer.
    Drzewiecka H, Gałęcki B, Jarmołowska-Jurczyszyn D, Kluk A, Dyszkiewicz W, Jagodziński PP.
    Lung Cancer; 2015 Feb; 87(2):107-16. PubMed ID: 25564397
    [Abstract] [Full Text] [Related]

  • 3. Mitochondrial Pyruvate Carrier 1 as a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer.
    Zou H, Yin Y, Xiong K, Luo X, Sun Z, Mao B, Xie Q, Tan M, Kong R.
    Technol Cancer Res Treat; 2024 Feb; 23():15330338241282080. PubMed ID: 39360506
    [Abstract] [Full Text] [Related]

  • 4. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L, Shan W, Zhang Y, Lv X, Li X, Wei C.
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [Abstract] [Full Text] [Related]

  • 5. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
    Jiang L, Liang X, Liu M, Wang W, Ma J, Guo Q, Han L, Yang C, Nan K.
    Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
    [Abstract] [Full Text] [Related]

  • 6. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X, Huang G, Zhang J, Zhang L, Liang Z.
    PLoS One; 2020 Nov; 15(10):e0240321. PubMed ID: 33052949
    [Abstract] [Full Text] [Related]

  • 7. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
    Zhang D, Jin X, Wang F, Wang S, Deng C, Gao Z, Guo C.
    Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP, Yan XL, Li WM, Ni YF, Zhao JB, Lu Q, Wang XJ, Sun Y, Chen P, Yan BY, Cui Y, Zhang ZP, Li XF.
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [Abstract] [Full Text] [Related]

  • 9. Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues.
    Chang CY, Chang SL, Leu JD, Chang YC, Hsiao M, Lin LT, Lin HN, Lee YJ.
    Oncol Rep; 2019 Aug; 42(2):805-816. PubMed ID: 31233187
    [Abstract] [Full Text] [Related]

  • 10. Knockdown of Nemo‑like kinase promotes metastasis in non‑small‑cell lung cancer.
    Shi C, Xu L, Tang Z, Zhang W, Wei Y, Ni J, Zhang S, Feng J.
    Oncol Rep; 2019 Sep; 42(3):1090-1100. PubMed ID: 31322229
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N, Shadvar S, Masoudi Y, Talaei AJ, Yahaghi E, Goudarzi PK, Shakiba E.
    Diagn Pathol; 2015 Sep 17; 10():164. PubMed ID: 26377406
    [Abstract] [Full Text] [Related]

  • 14. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H, Zeng F, Xu L, Liu X, Huang Y.
    Mol Med Rep; 2013 Nov 17; 8(5):1511-8. PubMed ID: 24008862
    [Abstract] [Full Text] [Related]

  • 15. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q, Fan J, Qian X, Lv Z, Zhang X, Han J, Wu F, Chen C, Du J, Guo M, Hu G, Jin Y.
    J Cancer Res Clin Oncol; 2016 Jan 17; 142(1):263-72. PubMed ID: 26319393
    [Abstract] [Full Text] [Related]

  • 16. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
    Feng A, Tu Z, Yin B.
    Oncotarget; 2016 Apr 12; 7(15):20507-19. PubMed ID: 26840258
    [Abstract] [Full Text] [Related]

  • 17. Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer.
    Qin H, Ni Y, Tong J, Zhao J, Zhou X, Cai W, Liang J, Yao X.
    Med Oncol; 2014 Aug 12; 31(8):142. PubMed ID: 25048725
    [Abstract] [Full Text] [Related]

  • 18. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 12; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

  • 19. CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression.
    Yin X, Xia J, Sun Y, Zhang Z.
    BMC Pulm Med; 2020 Feb 13; 20(1):40. PubMed ID: 32054470
    [Abstract] [Full Text] [Related]

  • 20. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
    You Q, Guo H, Xu D.
    Drug Des Devel Ther; 2015 Feb 13; 9():5087-97. PubMed ID: 26366059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.